China SXT Pharmaceuticals, Inc. (SXTC)
NASDAQ: SXTC · Real-Time Price · USD
1.780
-0.110 (-5.82%)
At close: Mar 16, 2026, 4:00 PM EDT
1.810
+0.030 (1.69%)
After-hours: Mar 16, 2026, 7:08 PM EDT
China SXT Pharmaceuticals Employees
China SXT Pharmaceuticals had 75 employees as of March 31, 2025. The number of employees did not change compared to the previous year.
Employees
75
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
$20,506
Profits / Employee
-$118,265
Market Cap
206.53M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Mar 31, 2025 | 75 | 0 | - |
| Mar 31, 2024 | 75 | -3 | -3.85% |
| Mar 31, 2023 | 78 | -10 | -11.36% |
| Mar 31, 2022 | 88 | -8 | -8.33% |
| Mar 31, 2021 | 96 | -1 | -1.03% |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Organigram Global | 1,137 |
| Aurora Cannabis | 1,073 |
| Canopy Growth | 960 |
| Organogenesis Holdings | 854 |
| Lifecore Biomedical | 406 |
| Evolus | 334 |
| Anika Therapeutics | 235 |
| Akebia Therapeutics | 194 |
SXTC News
- 6 weeks ago - China SXT Pharmaceuticals, Inc. Announces Share Consolidation - GlobeNewsWire
- 2 months ago - Univest Securities, LLC Announces Closing of $10 Million Registered Direct Offering for its Client China SXT Pharmaceuticals, Inc. (NASDAQ: SXTC) - GlobeNewsWire
- 2 months ago - China SXT Pharmaceuticals Inc. Announces $10 Million Registered Direct Offering - GlobeNewsWire
- 1 year ago - China SXT Pharmaceuticals Has Regained Compliance with Nasdaq's Minimum Bid Price Deficiency - GlobeNewsWire
- 1 year ago - China SXT Pharmaceuticals, Inc. Received Nasdaq Notification Letter Regarding Bid Price Deficiency - GlobeNewsWire
- 2 years ago - China SXT Pharmaceuticals, Inc. Regained Compliance with Nasdaq's Minimum Bid Price Rule - GlobeNewsWire
- 2 years ago - China SXT Pharmaceuticals Announces One-for-Twenty-five Reverse Stock Split - GlobeNewsWire
- 4 years ago - China SXT Pharmaceuticals, Inc. Announces 1 for 20 Reverse Share Split - GlobeNewsWire